Skin Cancer

>

Latest News

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug
Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

There are currently no FDA approved therapies in this treatment setting.

Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma
Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma

March 24th 2023

Skin Cancer Detection Device Backed by Studies
Skin Cancer Detection Device Backed by Studies

March 23rd 2023

Oral Vitamin D Supplementation May Lower Melanoma Risk
Oral Vitamin D Supplementation May Lower Melanoma Risk

March 22nd 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC
FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

Video Interviews
Podcasts
 The Cutaneous Connection
 The Cutaneous Connection: Episode 27
The Cutaneous Connection
The Cutaneous Connection
Latest CME Events & Activities

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma

04/29/2023

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire ®: Addressing the Top 10 Clinical Challenges in Melanoma

View More

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

View More

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

View More

Burst CME™: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Virtual Case Studies in Pustular Psoriasis: Refining Our Approaches to the Assessment of Our Patients

View More

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

View More

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

More News

© 2023 MJH Life Sciences

All rights reserved.